Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludrocortisone and D-Cycloserine for Cognition in Depression
NCT03062150Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Sep 2016
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of fludrocortisone in major depressive disorder (MDD) (4 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Emotional dot probe task performance at 1 hour. Started Sep 2016; status: completed.
02
Drugs
fludrocortisone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03062150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062150.